Rating Rationale
July 22, 2019 | Mumbai
Regency Hospital Limited
 
Rating Action
Total Bank Loan Facilities Rated Rs.193 Crore
Long Term Rating CRISIL BBB-/Stable
Short Term Rating CRISIL A3
1 crore = 10 million
Refer to annexure for Details of Instruments & Bank Facilities
Detailed Rationale

CRISIL rating on the bank facilties of Regency Hospital Limited (RHL) continue to reflect established market position in Kanpur, Uttar Pradesh and its adequate financial risk profile. These strengths are partially offset by RHL's sizeable expansion plans and high geographical concentration in revenue.

CRISIL had assigned its 'CRISIL A3' rating to the short-term bank facility of RHL. The long-term rating has been removed from 'Raing Watch with Developing Implications' while reaffirmed the rating at 'CRISIL BBB-' and assigned a 'Stable' outlook on March 13, 2019

Key Rating Drivers & Detailed Description
Strengths
* Healthy business risk profile: 
RHL is an established healthcare provider, with a track record of over 25 years in Kanpur. It operates two multi-specialty hospitals, one super-specialty renal care centre and HCG Regency, a cancer care centre, under a joint venture (JV) with HealthCare Global Enterprises Ltd. The company also runs a nursing school and a city clinic. The flagship multi-specialty hospital at Sarvodaya Nagar has 232 beds, with high occupancy of around 84% in fiscal 2019. RHL enjoys strong brand equity in Kanpur and adjoining areas, as it is the only tertiary care provider in the vicinity. However, the ability to improve occupancy and generate operating profit from new facilities, will remain a key monitorable.

* Adequate financial risk profile: Financial risk profile although adequate, has weakened following the absorption of HCG Regency in RHL. Gearing increased to 1.1 times as on March 31, 2018 from 0.54 time the previous year. However, with equity infusion of Rs 13.5 crore in fiscal 2019, gearing improved to 1.0 time as on March 31, 2019. Also, net cash accrual improved to Rs 17.1 crore on the back of ramp up in HCG Regency and RHL. In the medium term, capital structure is expected to further improve with gearing likely below 1 time, despite the debt-funded expansions of setting up a 150-bed hospital in Lucknow and a nursing college. Debt protection metrics are adequate: interest coverage and net cash accrual to adjusted debt stood at 2.3 times and 11%, respectively, in fiscal 2019.

Weaknesses
* Risks related to stabilisation and ramp-up of operations in newly added capacities:
RHL has been involved in various Greenfield expansion projects in the last five years. A facility each became operational in fiscals 2017, 2018, and 2019. More expansions are planned in fiscal 2020, funded by debt and internal accrual. CRISIL will continue to monitor the progress on these projects, and their impact on RHL's capital structure and debt protection metrics.

* Geographical concentration in revenue: All the health care facilities are based in Kanpur. Though these hospitals do cater to patients from adjoining areas in Uttar Pradesh, dependence on local patients remains high. Despite a multi-specialty hospital being set up in Lucknow, bulk of revenue will come from operations in Kanpur.
Liquidity

Liquidity is likely to remain adequate. Accrual should increase steadily to Rs 26-31 crore per annum, against maturing term debt of Rs 14.3-18.03 crore annually by fiscal 2021. Bank limit utilisation averaged 59% for the 12 months through June 2019. Equity infusion of Rs 13.5 crore in fiscal 2019 supports liquidity.

Outlook: Stable

CRISIL believes that RHL's business risk profile will improve over the medium term, with increasing utilisation of its enhanced capacities. The rating outlook may be revised to 'Positive' if increase in revenue and profitability leads to high cash accrual and prudent working capital management strengthens financial risk profile. The outlook may be revised to 'Negative' if decline in profitability or any large capital expenditure (capex) or any significant cash outflow towards the capex being undertaken weakens financial risk profile.

About the Company

RHL was incorporated as a private limited company in 1987 and reconstituted as a public limited company in 1992. Promoted by Dr Atul Kapoor and his wife, Dr Rashmi Kapoor, the company has multiple healthcare centres and hospitals in Kanpur. It has 6 operation theatres at its multi-specialty hospital, 3 at its renal care centre, and 3 at the newly set-up South Kanpur hospital. RHL also has a city clinic and a cancer care centre, which commenced operations in January 2017.

Key Financial Indicators
As on / for the period ended March 31  Units 2019* 2018
Revenue Rs crore 226.4 177.4
Profit after tax (PAT) Rs crore 4.13 2.35
PAT margin % 1.8 1.3
Adjusted debt/adjusted networth Times 1.03 1.09
Interest coverage Times 2.28 1.73
*Provisional Numbers

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments. The CRISIL complexity levels are available on www.crisil.com/complexity-levels. Users are advised to refer to the CRISIL complexity levels for instruments that they consider for investment. Users may also call the Customer Service Helpdesk with queries on specific instruments.
Annexure - Details of Instrument(s)
ISIN Name of instrument Date of allotment Coupon rate (%) Maturity date Issue size
(Rs crore)
Rating assigned with outlook
NA Cash credit NA NA NA 25.4 CRISIL BBB-/Stable
NA Letter of credit & bank guarantee NA NA NA 4.0 CRISIL A3
NA Long term loan NA NA Aug-2025 68.6 CRISIL BBB-/Stable
NA Term loan NA NA Mar-2027 95 CRISIL BBB-/Stable
Annexure - Rating History for last 3 Years
  Current 2019 (History) 2018  2017  2016  Start of 2016
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund-based Bank Facilities  LT/ST  189.00  CRISIL BBB-/Stable  13-03-19  CRISIL BBB-/Stable  24-12-18  CRISIL BBB-/Watch Developing  14-12-17  CRISIL BBB-/Stable      Suspended 
Non Fund-based Bank Facilities  LT/ST  4.00  CRISIL A3  13-03-19  CRISIL A3              Suspended 
All amounts are in Rs.Cr.
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Cash Credit 25.4 CRISIL BBB-/Stable Cash Credit 25.4 CRISIL BBB-/Stable
Letter of credit & Bank Guarantee 4 CRISIL A3 Letter of credit & Bank Guarantee 4 CRISIL A3
Long Term Loan 68.6 CRISIL BBB-/Stable Long Term Loan 133.6 CRISIL BBB-/Stable
Term Loan 95 CRISIL BBB-/Stable Term Loan 30 CRISIL BBB-/Stable
Total 193 -- Total 193 --
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Approach to Recognising Default
CRISILs Bank Loan Ratings
The Rating Process
Understanding CRISILs Ratings and Rating Scales

For further information contact:
Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
naireen.ahmed@crisil.com

Vinay Rajani
Media Relations
CRISIL Limited
D: +91 22 3342 1835
M: +91 91 676 42913
B: +91 22 3342 3000
vinay.rajani@ext-crisil.com

Mohit Makhija
Director - CRISIL Ratings
CRISIL Limited
B:+91 124 672 2000
mohit.makhija@crisil.com


Jaya Mirpuri
Associate Director - CRISIL Ratings
CRISIL Limited
D:+91 20 4018 1926
jaya.mirpuri@crisil.com


Madhulika Gupta
Rating Analyst - CRISIL Ratings
CRISIL Limited
B:+91 124 672 2163
Madhulika.Gupta@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a leading agile and innovative, global analytics company driven by its mission of making markets function better. We are India’s foremost provider of ratings, data, research, analytics and solutions. A strong track record of growth, culture of innovation and global footprint sets us apart. We have delivered independent opinions, actionable insights, and efficient solutions to over 1,00,000 customers.
 
We are majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.
 
For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 1,10,000 MSMEs have been rated by us.


CRISIL PRIVACY
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.CRISIL or its associates may have other commercial transactions with the company/entity.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL